Dexlansoprazole

In the US, Dexlansoprazole (dexlansoprazole systemic) is a member of the drug class proton pump inhibitors and is used to treat Barrett's Esophagus, Erosive Esophagitis and GERD.

US matches:

• Dexlansoprazole Delayed-Release Capsules


• Dexlansoprazole

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0138530-94-6

Chemical Formula

C16-H14-F3-N3-O2-S

Molecular Weight

369

Therapeutic Categories

Gastric acid secretion inhibitor

Treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD)

Proton pump inhibitor, PPI

Chemical Names

(+)-2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl]-1H-benzamidazole (WHO)

1H-Benzimidazole, 2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-sulfinyl]- (USAN)

Foreign Names

• Dexlansoprazolum (Latin)
• Dexlansoprazol (German)
• Dexlansoprazole (French)
• Dexlansoprazol (Spanish)

Generic Names

• Dexlansoprazole (OS: USAN)
• T-168390 (IS)
• TAK-390 (IS)
• TAK-390 MR (IS)
• UNII-UYE4-T5I70X (IS)

Brand Name

• Kapidex
  Takeda, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.